“This is really the thing we look forward to all year and we weren’t going to let the pandemic get in the way this year,” said DCI exec. director Michael Kastan, MD, PhD.
The burden of care after breast cancer treatment is on oncologists, other specialists & primary care providers. Here's a new Duke-edited guide for treating survivors.
Here are some of the DCI physicians, physician-scientists, researchers & nurses whose work has recently been featured by the media, academic trade publications & journals.
Carolyn Menendez, MD, FACS, assistant professor of Surgical Oncology has been appointed director of Duke Cancer Institute’s Clinical Cancer Genetics Program.